BAUSCH AND LOMB Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH AND LOMB, and when can generic versions of BAUSCH AND LOMB drugs launch?
BAUSCH AND LOMB has eighty-two approved drugs.
There are forty-nine US patents protecting BAUSCH AND LOMB drugs.
There are four hundred and seventy-one patent family members on BAUSCH AND LOMB drugs in forty-seven countries and eighty supplementary protection certificates in fifteen countries.
Summary for BAUSCH AND LOMB
| International Patents: | 471 |
| US Patents: | 49 |
| Tradenames: | 75 |
| Ingredients: | 58 |
| NDAs: | 82 |
Drugs and US Patents for BAUSCH AND LOMB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate; neomycin sulfate | SOLUTION/DROPS;OPHTHALMIC | 064055-001 | Oct 30, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bausch And Lomb | OPCON | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 087506-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bausch And Lomb Inc | LUMIFY | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 208144-001 | Dec 22, 2017 | OTC | Yes | Yes | 9,259,425 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAUSCH AND LOMB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | TIMOPTIC-XE | timolol maleate | SOLUTION, GEL FORMING/DROPS;OPHTHALMIC | 020330-001 | Nov 4, 1993 | 4,861,760 | ⤷ Try a Trial |
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | 6,217,895 | ⤷ Try a Trial |
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | 6,548,078 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
International Patents for BAUSCH AND LOMB Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20200108932 | ⤷ Try a Trial |
| China | 106511322 | ⤷ Try a Trial |
| Denmark | 1704141 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BAUSCH AND LOMB Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0694547 | SPC/GB02/027 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425 |
| 0694547 | 03C0003 | France | ⤷ Try a Trial | PRODUCT NAME: VALGANCICLOVIR AINSI QUE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET EN PARTICULIER LE CHLORHYDRATE; NAT. REGISTRATION NO/DATE: NL 27380 20021016; FIRST REGISTRATION: NL - RVG 25 992 20010920 |
| 0957929 | PA2006004,C0957929 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PEGAPTANIBUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
